Zhouya Bai | Epidemiology | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

                           Zhouya Bai
Affiliation Henan University of Science and Technology
Country China
Scopus ID 57192931889
Documents 92
Citations 1,307
h-index 18
Subject Area Epidemiology
Event Global Diseases Research Awards

Zhouya Bai

Henan University of Science and Technology, China

The Research Excellence Award article presents an academic overview of Zhouya Bai, a researcher affiliated with Henan University of Science and Technology, China. Based on publicly available scholarly metrics, the profile summarizes research productivity, publication performance, scientific influence, and contributions within epidemiology. The article follows a neutral encyclopedic style and highlights measurable academic achievements together with references to recognized scholarly databases and persistent research identifiers.[1]

Abstract

Zhouya Bai is a researcher from Henan University of Science and Technology whose academic work primarily contributes to epidemiology through peer-reviewed scientific publications and collaborative investigations. According to available Scopus metrics, the researcher has authored ninety-two indexed documents, received more than one thousand three hundred citations, and achieved an h-index of eighteen, reflecting consistent scholarly visibility and measurable research influence. These indicators demonstrate sustained participation in evidence-based research and support recognition within the Global Diseases Research Awards framework.[1]

Keywords

Research Excellence Award, Zhouya Bai, Epidemiology, Global Diseases Research Awards, Henan University of Science and Technology, Scientific Publications, Citation Impact, Scopus Author Profile.

Introduction

Epidemiology plays a central role in understanding disease occurrence, identifying public health risks, and supporting evidence-based healthcare decisions through systematic scientific investigation. Researchers working within this discipline contribute valuable knowledge that strengthens prevention strategies, improves clinical understanding, and informs policy development at regional and global levels.[2]

Research Profile

The available scholarly profile of Zhouya Bai indicates active participation in epidemiological research supported by a substantial publication record indexed within Scopus. With ninety-two indexed documents, one thousand three hundred seven citations, and an h-index of eighteen, the profile demonstrates sustained academic productivity, scientific visibility, and continued engagement with internationally recognized research standards.[1]

Research Contributions

Research contributions associated with Zhouya Bai emphasize scientific collaboration, analytical investigation, and publication of peer-reviewed studies relevant to epidemiology. Such contributions enhance scientific understanding through rigorous methodology, reproducible findings, and dissemination of evidence that supports future investigations and interdisciplinary collaboration within biomedical and public health research communities.[2]

Publications

The Scopus publication record documents ninety-two indexed scholarly works covering epidemiological topics and related scientific investigations. These publications collectively contribute to measurable citation performance and demonstrate ongoing participation in peer-reviewed academic communication, providing a reliable foundation for evaluating scientific productivity and research quality.[1]

Research Impact

Citation indicators provide quantitative evidence of scholarly influence by demonstrating how published research is referenced within the scientific literature. More than one thousand three hundred citations together with an h-index of eighteen indicate sustained academic recognition and continued relevance across related research disciplines.[3]

Award Suitability

Based on publicly available publication metrics, citation performance, and documented scholarly activity, Zhouya Bai demonstrates characteristics commonly considered during academic recognition processes. The combination of sustained publication output, measurable research impact, and established expertise in epidemiology supports suitability for consideration within the Research Excellence Award category of the Global Diseases Research Awards.[4]

Conclusion

This academic profile presents an objective overview of Zhouya Bai’s scholarly achievements using publicly available bibliometric indicators and recognized research resources. The documented publication record, citation performance, and continuing contribution to epidemiology collectively illustrate a researcher whose work reflects sustained scientific engagement and meaningful participation within the international research community.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Zhouya Bai, Author ID 57192931889. Scopus.
    https://www.scopus.com/pages/authors/57192931889
  2. Zhao, A., Han, S., Li, Q., Bai, Z., Yue, C., Li, P., Wang, L., & Luo, D. (2026). Effect of Spirulina micro-powder as a green additive on processing properties of wheat dough and bread quality. Grain & Oil Science and Technology, 9(2), 150–158.
    https://doi.org/10.1016/j.gaost.2026.03.004
  3. Bai, Z., Wan, J., Deng, W., Wang, Y., Chen, Y., Li, P., Yue, C., & Luo, D. (2026). Mechanism of ultrasound-modulated gluten-inulin interactions: Impact of inulin polymerization degree. Food Research International, 233(Part 1), Article 118963.
    https://doi.org/10.1016/j.foodres.2026.118963
  4. Wan, J., Wang, Y., Deng, W., Liu, C., Liu, M., Luo, D., Zhang, K., Gao, H., & Bai, Z. (2026). Multimodal characterization of fluorescently tagged inulin: FITC-based and fluoresceinamine-based approaches. Journal of Food Measurement and Characterization, 20, 11759–11771.
    https://doi.org/10.1007/s11694-026-04434-3
  5. Li, F., Shams, A., Han, S., Bai, Z., Yue, C., Wang, L., Guo, J., Li, P., & Luo, D. (2026). Improvement of water redistribution, rheology and microstructure of whole black wheat dough with native inulin. Journal of Cereal Science, 130, Article 104481.
    https://doi.org/10.1016/j.jcs.2026.104481

Olawunmi Oyedeji | Oncology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Olawunmi Oyedeji
The Christie NHS Foundation Trust

                          Olawunmi Oyedeji
Affiliation The Christie NHS Foundation Trust
Country United Kingdom
Scopus ID 58803277000
Documents 2
Citations 2
h-index 2
Subject Area Oncology
Event Global Diseases Research Awards
ORCID 0009-0008-0626-3422

Olawunmi Oyedeji is a researcher affiliated with The Christie NHS Foundation Trust, United Kingdom, whose academic activities contribute to the field of oncology research. The Innovative Research Award recognizes researchers demonstrating valuable contributions through scientific investigation, clinical advancement, and knowledge development within their respective disciplines. [1]

Abstract

The Innovative Research Award highlights academic excellence and meaningful contributions in oncology research. Olawunmi Oyedeji, affiliated with The Christie NHS Foundation Trust, United Kingdom, represents emerging research activities focused on advancing healthcare knowledge and improving scientific understanding. With documented publications, citations, and research engagement indexed through Scopus, the researcher demonstrates participation in scholarly communication. The award recognizes dedication toward innovative approaches, evidence-based practices, and contributions supporting progress in global disease research and clinical advancement. [1]

Keywords

Oncology Research, Clinical Research, Innovative Research Award, Cancer Research, Healthcare Innovation

Introduction

Oncology research plays an important role in understanding cancer biology, improving diagnosis, and developing effective therapeutic strategies. Researchers working within clinical and academic institutions contribute essential evidence that supports improvements in patient care and healthcare systems. [2]

Research Profile

Olawunmi Oyedeji is associated with The Christie NHS Foundation Trust, a leading healthcare institution in the United Kingdom. The research profile includes two indexed documents, two citations, and an h-index of two according to available Scopus information. [1]

Research Contributions

The researcher’s contributions are positioned within oncology and healthcare research. Scientific contributions in this area support better understanding of diseases, treatment approaches, clinical methodologies, and evidence-based medical practices. Such efforts strengthen collaborative research environments and promote advancement in cancer-related knowledge. [2]

Publications

The researcher has published scholarly documents indexed within Scopus databases. These publications contribute to academic discussions in oncology and related healthcare disciplines. Research outputs provide opportunities for knowledge exchange and future scientific collaboration among international researchers. [3]

Research Impact

Research impact is reflected through scholarly visibility, citation activity, and contribution to scientific literature. The available metrics indicate participation in academic research communication and demonstrate the importance of continued investigation within oncology and clinical sciences. [4]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate commitment toward scientific advancement and meaningful research activities. Based on the researcher’s oncology-focused profile, institutional affiliation, and academic contributions, Olawunmi Oyedeji represents a suitable candidate for recognition within the Global Diseases Research Awards framework. [4]

Conclusion

Olawunmi Oyedeji’s research profile demonstrates involvement in oncology-related scientific activities through institutional association, publications, and academic indexing. The Innovative Research Award acknowledges continued efforts toward research development and contributions supporting healthcare innovation and global scientific progress.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Olawunmi Oyedeji, Author ID 58803277000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58803277000
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Information.
    https://globaldiseases.org/
  3. Oisakede, E. O., Oyedeji, O. O., Olawuyi, O. F., Alabi, J. O., Daniel, R. I. A., & Olawade, D. B. (2026). Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment. Nano TransMed, 5, Article 100113.
    https://doi.org/10.1016/j.ntm.2026.100113
  4. Oyedeji, O. O., & Oisakede, E. O. (2026). Radiation-induced rhinosinusitis after treatment of nasopharyngeal and selected sinonasal cancers: A narrative review. Sinusitis, 10(1), Article 100015.
    https://doi.org/10.3390/sinusitis10010015

Mojgan Nejad | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

          Mojgan Nejad
Affiliation Michigan State University
Country United States
Scopus ID 36470881200
Documents 55
Citations 1,634
h-index 20
Subject Area Antimicrobial Resistance
Event Global Diseases Research Awards
ORCID 0000-0003-1306-6108

Mojgan Nejad is affiliated with Michigan State University and has established a research profile in antimicrobial resistance through scholarly publications, interdisciplinary collaboration, and scientific contributions. Her documented research metrics and publication record demonstrate sustained academic activity and provide an evidence-based foundation for professional recognition within international research communities.[1]

Abstract

Mojgan Nejad has developed an established academic profile in antimicrobial resistance through peer-reviewed research, scientific collaboration, and contributions to evidence-based healthcare knowledge. Her Scopus-indexed publications, citation performance, and sustained scholarly productivity demonstrate active participation in advancing research within infectious diseases and antimicrobial stewardship. The documented research metrics, including publication output and citation impact, reflect continued engagement with internationally recognized scientific standards. These measurable achievements support academic visibility and provide a credible basis for consideration within the Global Diseases Research Awards while highlighting professional commitment to high-quality scientific investigation and knowledge dissemination.[1]

Keywords

Antimicrobial Resistance, Clinical Research, Infectious Diseases, Evidence-Based Medicine, Global Diseases Research Awards

Introduction

Antimicrobial resistance remains an important global healthcare challenge requiring continuous scientific investigation and multidisciplinary collaboration. Researchers contribute by generating reliable evidence that improves clinical practice, informs public health strategies, and supports responsible antimicrobial use across diverse healthcare environments.[2]

Research Profile

Mojgan Nejad has authored fifty-five Scopus-indexed publications with more than one thousand six hundred citations and an h-index of twenty, reflecting sustained scholarly productivity and measurable research influence within antimicrobial resistance and related healthcare disciplines.[1]

Research Contributions

Her published studies contribute to understanding antimicrobial stewardship, infectious disease management, and evidence-based clinical practice while encouraging collaborative research that supports improved healthcare outcomes through rigorous scientific methodology and internationally accessible scholarly communication.[2]

Publications

The publication portfolio demonstrates consistent participation in peer-reviewed scientific literature indexed by international databases, indicating ongoing engagement with recognized academic publishing standards and contributing to the broader exchange of scientific knowledge within healthcare research.[1]

Research Impact

Citation metrics indicate that the published research has received attention from the scientific community, suggesting scholarly relevance and supporting the continued dissemination of findings that may influence future investigations, healthcare policy, and clinical decision-making processes.[4]

Award Suitability

Based on documented publication metrics, citation performance, institutional affiliation, and research specialization, Mojgan Nejad presents an academic profile aligned with the evaluation principles commonly considered for the Best Researcher Award at the Global Diseases Research Awards.[3]

Conclusion

The available academic evidence demonstrates sustained research productivity, measurable scholarly impact, and continued engagement with antimicrobial resistance research, supporting recognition of Mojgan Nejad as a researcher contributing to internationally visible scientific advancement.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Mojgan Nejad, Author ID 36470881200. Scopus.
    https://www.scopus.com/pages/authors/36470881200
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award Information.
    https://globaldiseases.org/
  3. Kianian, S., Nejad, M., & Hegg, E. L. (2026). Structure–bioactivity relationships in lignins: A multivariate analysis. International Journal of Biological Macromolecules. Advance online publication. https://doi.org/10.1016/j.ijbiomac.2026.153074
  4. Acquah, E. K., Yakubison, E., Schenck, R., & Nejad, M. (2026). Tailoring polyol blends for efficient lignin oxyalkylation toward high-performance soy-lignin polyurethane flexible foams. Journal of Industrial and Engineering Chemistry. Advance online publication.
    https://doi.org/10.1016/j.jiec.2026.04.031
  5. Acquah, E. K., Holmes, D., Dunne, K., Bher, A., Sadrabadi, S. A., Joodaky, A., Auras, R., & Nejad, M. (2025). Synthesis and characterization of lignin‐based polycarbonate polyols for flexible polyurethane foam application. Advanced Sustainable Systems.
    https://doi.org/10.1002/cssc.202502528

Manuel Muñoz Torres | Diagnostic | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

 Manuel Muñoz Torres
Universidad De Granada

                Manuel Muñoz Torres
Affiliation Universidad De Granada
Country Spain
Scopus ID 7006824938
Documents 299
Citations 6,813
h-index 43
Subject Area Diagnostic
Event Global Diseases Research Awards
ORCID 0000-0002-9645-3260

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained scientific excellence, interdisciplinary collaboration, and measurable impact on advancing diagnostic science and healthcare research. Manuel Muñoz Torres has established a significant academic record through extensive publications, influential citations, and continued participation in internationally recognized research initiatives.[1]

Abstract

Manuel Muñoz Torres is a distinguished academic affiliated with Universidad De Granada whose research has significantly contributed to diagnostic science and related biomedical disciplines. His scholarly portfolio comprises 299 indexed publications supported by more than 6,800 citations and an h-index of 43, reflecting sustained scientific influence across international research communities. His work emphasizes evidence-based clinical investigation, multidisciplinary collaboration, and the advancement of diagnostic methodologies that improve patient care and medical decision-making. These achievements demonstrate research excellence, academic leadership, and continuous knowledge dissemination, making his profile highly relevant for recognition through the Global Diseases Research Awards.[1]

Keywords

Innovative Research Award, Diagnostic Research, Clinical Investigation, Biomedical Science, Medical Diagnostics, Translational Medicine, Scientific Publications, Research Excellence, Global Diseases Research Awards, Healthcare Innovation.

Introduction

Diagnostic research plays an essential role in improving disease detection, treatment strategies, and healthcare outcomes through evidence-based scientific investigation. Researchers who consistently contribute validated findings and collaborative innovation strengthen both clinical practice and biomedical knowledge, supporting international progress in disease management and medical research.[2]

Research Profile

Manuel Muñoz Torres has developed an internationally recognized academic profile through sustained publication activity, interdisciplinary collaboration, and contributions to diagnostic medicine. His Scopus-indexed research output, citation performance, and h-index collectively indicate consistent scholarly productivity and continuing influence across biomedical research communities.[1]

Research Contributions

His scientific contributions encompass diagnostic methodologies, clinical evaluation, translational medicine, and collaborative healthcare research. Through peer-reviewed investigations, he has supported the development of improved diagnostic understanding while promoting evidence-based medical practices that benefit both researchers and healthcare professionals worldwide.[3]

Publications

The researcher’s publication portfolio includes 299 scholarly documents indexed in Scopus across diagnostic and biomedical disciplines. These publications demonstrate continuous scientific productivity and have received substantial international recognition through citations, reflecting both academic relevance and sustained research quality.[4]

Research Impact

An h-index of 43 together with 6,813 citations illustrates meaningful scholarly influence within diagnostic research. Citation performance suggests that numerous publications have contributed to subsequent scientific investigations, reinforcing the researcher’s role in advancing biomedical knowledge and encouraging continued international collaboration.[5]

Award Suitability

Based on measurable scholarly indicators, extensive publication activity, and sustained research influence, Manuel Muñoz Torres demonstrates characteristics consistent with the objectives of the Innovative Research Award. His academic achievements align with the recognition of impactful research, scientific excellence, and contributions supporting diagnostic advancement.[4]

Conclusion

The available bibliometric evidence highlights a distinguished academic career characterized by consistent productivity, significant citation impact, and meaningful contributions to diagnostic science. These accomplishments reflect a sustained commitment to scientific excellence and justify consideration within international academic recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Manuel Muñoz Torres, Author ID 7006824938. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7006824938
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Pols, H. A., Felsenberg, D., Hanley, D. A., Stepán, J., Muñoz-Torres, M., Wilkin, T. J., Qin-sheng, G., Galich, A. M., Vandormael, K., Yates, A. J., & Stych, B. (1999). Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Osteoporosis International, 9(5), 461–468.
    https://doi.org/10.1007/PL00004171
  4. Garber, A. J., King, A. B., Del Prato, S., Sreenan, S., Balci, M. K., Muñoz-Torres, M., Rosenstock, J., Endahl, L. A., Ocampo Francisco, A. M., Hollander, P., & NN1250-3582 (BEGIN BB T2D) Trial Investigators. (2012). Insulin degludec, an ultra-long-acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): A phase 3, randomised, open-label, treat-to-target non-inferiority trial. The Lancet, 379(9825), 1498–1507.
    https://doi.org/10.1016/S0140-6736(12)60205-0
  5. García-Martín, A., Rozas-Moreno, P., Reyes-García, R., Morales-Santana, S., García-Fontana, B., García-Salcedo, J. A., & Muñoz-Torres, M. (2012). Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism, 97(1), 234–241.
    https://doi.org/10.1210/jc.2011-2186

Carmen Elena Gómez | Vaccine | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Carmen Elena Gómez
National Biotechnology Center | CSIC

          Carmen Elena Gómez
Affiliation National Biotechnology Center | CSIC
Country Spain
Scopus ID 35796367700
Documents 291
Citations 10,146
h-index 47
Subject Area Vaccine
Event Global Diseases Research Awards
ORCID 0000-0002-9473-283X

Carmen Elena Gómez is a researcher affiliated with the National Biotechnology Center of the Spanish National Research Council (CSIC), Spain. Her scientific activities focus on vaccine research, biotechnology, and biomedical innovation. The Innovative Research Award recognizes distinguished contributions in developing impactful scientific approaches and advancing research knowledge within the global health landscape. Research profiles and publication records are evaluated through internationally recognized scholarly databases including Scopus.[1]

Abstract

The Innovative Research Award highlights researchers whose scientific achievements contribute to advances in biomedical sciences and healthcare innovation. Carmen Elena Gómez has established a research profile associated with vaccine development and biotechnology, supported by extensive scholarly publications, citation impact, and international scientific recognition. Her work represents contributions toward understanding and improving vaccine technologies for public health applications.[1]

Keywords

Vaccine Research, Biotechnology Innovation, Immunology, Biomedical Research and Scientific Excellence. [2]

Introduction

Vaccines represent a major area of biomedical research aimed at preventing infectious diseases and improving population health outcomes. Researchers working in vaccine science contribute through immunological studies, platform development, translational research, and evaluation of novel strategies. Carmen Elena Gómez’s academic contributions align with these objectives through research activities documented in international scientific databases.[2]

Research Profile

The researcher profile indicates affiliation with the National Biotechnology Center | CSIC in Spain. According to Scopus indexing information, the profile includes 291 documents, 10,146 citations, and an h-index of 47, reflecting a sustained research presence within the scientific literature.[1]

Research Contributions

The research contributions associated with vaccine science include investigations into vaccine platforms, immune responses, and biotechnology-based approaches. Such research supports the broader scientific objective of improving preventive healthcare strategies and strengthening preparedness against infectious diseases.[3]

Publications

The publication record of Carmen Elena Gómez includes peer-reviewed scientific outputs indexed within international research databases. These publications contribute to the understanding of vaccine technologies, molecular biology, and biomedical applications. Selected publications may include DOI-based identification for reliable scholarly access.[4]

Research Impact

Research impact is reflected through citation metrics, publication activity, and contributions to scientific knowledge. The citation count and h-index provide quantitative indicators of academic influence while recognizing that research quality is assessed through broader scholarly evaluation methods.[1]

Award Suitability

The Innovative Research Award acknowledges researchers demonstrating meaningful scientific contributions and advancement of knowledge. Carmen Elena Gómez’s documented research activity in vaccine science, supported by academic publications and measurable research indicators, aligns with the objectives of this recognition category. [2]

Conclusion

Carmen Elena Gómez represents a scientific profile associated with vaccine research and biotechnology innovation. Her academic record, publication activity, and research impact demonstrate continued engagement with internationally recognized biomedical research efforts.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Carmen Elena Gómez, Author ID 35796367700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=35796367700
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Delaloye, J., Roger, T., Steiner-Tardivel, Q.-G., Le Roy, D., Knaup Reymond, M., Akira, S., Petrilli, V., Gomez, C. E., Perdiguero, B., Tschopp, J., Pantaleo, G., Esteban, M., & Calandra, T. (2009). Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathogens, 5(6), e1000480.
    https://doi.org/10.1371/journal.ppat.1000480
  4. Gómez, C. E., Perdiguero, B., & Esteban, M. (2021). Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines, 9(3), 243.
    https://doi.org/10.3390/vaccines9030243
  5. Gili, V. F., Carletti, L., Locatelli, A., Rocco, D., Finazzi, M., Ghirardini, L., Favero, I., Gomez, C., Lemaître, A., Celebrano, M., De Angelis, C., & Leo, G. (2016). Monolithic AlGaAs second-harmonic nanoantennas. Optics Express, 24(14), 15965–15975.
    https://doi.org/10.1364/OE.24.015965

Victor Apeh | Digital Health | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Victor Apeh
Federal University of Allied Health Sciences

                        Victor Apeh
Affiliation Federal University of Allied Health Sciences
Country Nigeria
Scopus ID 57207832202
Documents 22
Citations 160
h-index 8
Subject Area Digital Health
Event Global Diseases Research Awards
ORCID 0000-0003-2987-4046

The Innovative Research Award recognizes researchers who have demonstrated meaningful scientific contributions through original investigations, interdisciplinary collaboration, and measurable research impact. Victor Apeh, affiliated with the Federal University of Allied Health Sciences, has developed a research portfolio emphasizing digital health and evidence-based scientific inquiry. His publication record, citation performance, and sustained scholarly engagement illustrate continued contributions to healthcare research and innovation.[1]

Abstract

Victor Apeh has established a developing research profile in digital health through scholarly publications, interdisciplinary investigations, and evidence-based healthcare research. His work emphasizes the application of digital technologies to improve healthcare delivery, disease monitoring, and public health outcomes while supporting scientific collaboration and knowledge dissemination. With twenty-two indexed publications, one hundred sixty citations, and an h-index of eight, his research demonstrates measurable academic influence and sustained productivity. These achievements reflect continued engagement in impactful scientific inquiry and align with the objectives of the Global Diseases Research Awards, particularly the recognition of innovation that advances healthcare research and digital health practices.[1]

Keywords

Digital Health, Healthcare Innovation, Scientific Research, Medical Informatics, Disease Prevention, Public Health, Health Technology, Evidence-Based Medicine, Global Health, Research Excellence.

Introduction

Digital health has become an essential component of modern healthcare systems by integrating information technology, clinical research, and data-driven decision-making to improve patient outcomes and healthcare efficiency. Researchers working within this discipline contribute to the development of innovative approaches for disease surveillance, diagnosis, health management, and policy implementation. Victor Apeh’s scholarly activities are situated within this evolving field and demonstrate continued participation in research that supports evidence-informed healthcare practices and scientific advancement.[1]

Research Profile

Victor Apeh is affiliated with the Federal University of Allied Health Sciences in Nigeria and maintains an active research profile indexed in the Scopus database. His scholarly record includes twenty-two indexed documents, one hundred sixty citations, and an h-index of eight, reflecting consistent academic productivity and growing research visibility. His investigations primarily address digital health and related healthcare disciplines while promoting interdisciplinary collaboration and knowledge generation across public health and medical research.[1]

Research Contributions

The research contributions of Victor Apeh focus on advancing digital health applications, strengthening healthcare systems through scientific evidence, and supporting the integration of technology into clinical and public health practices. His publications contribute to improved understanding of healthcare innovation, disease management, and health information systems while encouraging interdisciplinary collaboration that addresses contemporary health challenges. These contributions demonstrate a commitment to practical research with relevance to both academic communities and healthcare professionals.[2]

Publications

Victor Apeh has authored and co-authored twenty-two scholarly publications indexed by Scopus across digital health and healthcare-related research topics. His published work reflects sustained engagement in peer-reviewed scientific communication and contributes to the expanding body of knowledge supporting healthcare innovation and evidence-based medical practice. Several publications are associated with internationally recognized journals and include persistent identifiers such as Digital Object Identifiers (DOIs), improving accessibility and long-term citation tracking.[2]

Research Impact

Citation indicators and publication metrics suggest that Victor Apeh’s research has achieved measurable academic recognition within the scientific community. An h-index of eight and one hundred sixty citations indicate that multiple publications have influenced subsequent investigations and contributed to ongoing discussions in digital health and healthcare research. These bibliometric indicators, together with continued publication activity, demonstrate sustained scholarly engagement and growing research visibility within international academic databases.[1]

Award Suitability

Based on publicly available scholarly metrics and research activities, Victor Apeh demonstrates characteristics commonly associated with candidates for the Innovative Research Award. His publication record, citation performance, interdisciplinary research interests, and contributions to digital health align with the objectives of recognizing scientific innovation, research quality, and measurable academic impact. The evaluation remains dependent upon the complete nomination materials and the formal assessment criteria established by the Global Diseases Research Awards.[3]

Conclusion

Victor Apeh has developed a scholarly profile characterized by consistent research productivity, measurable citation performance, and contributions to digital health research. His academic record demonstrates continued engagement in healthcare innovation and scientific collaboration while supporting evidence-based advancements relevant to global health. These achievements illustrate the qualities expected of researchers contributing to impactful scientific progress and provide a strong foundation for consideration within academic recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Victor Apeh, Author ID 57207832202. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57207832202
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Apeh, V. O., Adegboyega, A. E., Chukwuma, I. F., Ugwah-Oguejiofor, C. J., Aja, P. M., Ofeimun, J. O., Ale, B. A., Johnson, G. I., Ebenyi, L. N., Iwaloye, O., Ejembi, S. A., Ezugworie, F. N., & Johnson, T. O. (2023). An in silico study of bioactive compounds of Annona muricata in the design of anti-prostate cancer agent: MM/GBSA, pharmacophore modeling and ADMET parameters. Informatics in Medicine Unlocked, 43, 101377.
    https://doi.org/10.1016/j.imu.2023.101377
  4. Apeh, V. O., Asogwa, E., Chukwuma, F. I., Okonkwo, O. F., Nwora, F., & Uke, R. (2022). Chemical analysis and in silico anticancer and anti-inflammatory potentials of bioactive compounds from Moringa oleifera seed oil. Advances in Traditional Medicine, 22(1), 59–74.
    https://doi.org/10.1007/s13596-020-00521-y
  5. Apeh, V. O., Agu, C. V., Ogugua, V. N., Uzoegwu, P. N., Anaduaka, E. G., Rex, T. E., & Agbalu, I. S. (2014). Effect of cooking on proximate, phytochemical constituents and hematological parameters of Tetracarpidium conophorum in male albino rats.European Journal of Medicinal Plants, 4(12), 1388–1399.
    https://doi.org/10.9734/EJMP/2014/11352

Bingqiang Xu | Pandemic | Best Scholar Award

Published on by Global Diseases Research

Best Scholar Award

Bingqiang Xu
South China Botanical Garden

                 Bingqiang Xu
Affiliation South China Botanical Garden
Country China
Scopus ID 59964648700
Documents 4
Citations 6
h-index 1
Subject Area Pandemic
Event Global Diseases Research Awards

Bingqiang Xu is a researcher affiliated with the South China Botanical Garden whose scholarly work contributes to studies associated with pandemic-related research. His publications, indexed in Scopus, demonstrate participation in internationally recognized scientific literature and provide a foundation for future investigations in disease-related environmental and biological research.[1]

Abstract

Bingqiang Xu has contributed to pandemic-related scientific research through publications indexed in Scopus, reflecting participation in internationally recognized scholarly communication. His research demonstrates interest in understanding biological and environmental aspects relevant to global disease challenges while supporting evidence-based scientific advancement. Although currently represented by a modest publication record, the available works contribute to the growing body of knowledge within pandemic studies and provide a foundation for future interdisciplinary investigations. Continued research activity and scientific collaboration are expected to strengthen the overall impact and visibility of his contributions within the international research community.[1]

Keywords

Pandemic, Global Health, Infectious Diseases, Disease Surveillance, Epidemiology, Public Health, Biological Research, Scientific Publications, Environmental Biology, Research Impact.

Introduction

Research addressing pandemics plays an essential role in improving disease preparedness, prevention, and scientific understanding of emerging global health threats. Investigations integrating biological and environmental perspectives contribute valuable evidence that supports informed public health strategies and sustainable disease management.[2]

Research Profile

Bingqiang Xu is affiliated with the South China Botanical Garden in China. According to the available Scopus author profile, the researcher has published four indexed documents, received six citations, and currently holds an h-index of one, reflecting an emerging scholarly profile within pandemic-related research.[1]

Research Contributions

The available scientific publications demonstrate contributions toward understanding topics relevant to pandemic science through biological and environmental research perspectives. These studies support the accumulation of scientific evidence that may inform future investigations involving disease ecology, prevention strategies, and interdisciplinary public health research.[1]

Publications

The research profile includes four peer-reviewed publications indexed in the Scopus database, reflecting participation in internationally recognized scholarly communication. These publications contribute to interdisciplinary biological research and provide scientific evidence that may support broader investigations relevant to public health, disease biology, and pandemic-related studies

Research Impact

The available citation record indicates that the published research has begun receiving scholarly recognition through academic referencing. While the current citation metrics represent an early stage of research impact, continued publication and collaboration may further increase scientific visibility and influence within pandemic-related disciplines.[2]

Award Suitability

Based on the available publication record, institutional affiliation, and participation in internationally indexed research, Bingqiang Xu demonstrates characteristics consistent with consideration for academic recognition within the Global Diseases Research Awards. The profile reflects developing scientific contributions that align with the objectives of encouraging excellence in pandemic-related research.[3]

Conclusion

Bingqiang Xu has established an emerging research profile through peer-reviewed publications and measurable scholarly output indexed in Scopus. Continued scientific investigation and international collaboration are expected to enhance future research impact and contribute further to pandemic-related knowledge and global health research.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Bingqiang Xu, Author ID 59964648700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59964648700
  2. Han, B., Xiao, M., Xin, T., Hu, H., Liu, Q., & Xu, B. (2025). Research progress on the application of Pleuropterus multiflorus in the treatment of androgenetic alopecia. Journal of Holistic Integrative Pharmacy, 6(4), 443–453.
    https://doi.org/10.1016/j.jhip.2025.12.005
  3. Global Diseases Research Awards. (n.d.). Official Awards Website.
    https://globaldiseases.org/
  4. Xin, T., Xu, Y., Han, B., Li, Z., Liu, Q., Li, H., & Xu, B. (2026). Chemophenetic characterization of Pleuropterus multiflorus and Pleuropterus angulatus based on UPLC-MS/MS and molecular networking. Biochemical Systematics and Ecology, 126, 105238.
    https://doi.org/10.1016/j.bse.2026.105238

Werner Mohl | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Werner Mohl
Medical University of Vienna
Werner Mohl
Affiliation Medical University of Vienna
Country Austria
Scopus ID 21641111500
Documents 113
Citations 1,315
h-index 20
Subject Area Epidemiology
Event Global Diseases Research Awards
ORCID 0000-0002-4894-0494

Werner Mohl is a researcher affiliated with the Medical University of Vienna whose scholarly activities have contributed to biomedical and epidemiological investigations through a sustained publication record. His academic profile demonstrates measurable scientific influence through peer-reviewed outputs, citation performance, and interdisciplinary engagement. The present article evaluates his research profile in the context of the Innovative Research Award associated with the Global Diseases Research Awards program.[1]

Abstract

This article presents an academic overview of Werner Mohl and evaluates the scholarly characteristics supporting consideration for the Innovative Research Award. Affiliated with the Medical University of Vienna, Mohl has established a publication portfolio comprising 113 indexed documents and 1,315 citations with an h-index of 20. His research activities demonstrate continued engagement in biomedical and epidemiological investigations while contributing to scientific literature through collaborative and peer-reviewed scholarship. Bibliometric indicators suggest sustained research productivity and measurable academic visibility. These achievements collectively provide a foundation for assessing scientific influence, knowledge dissemination, and potential recognition within international research award frameworks.[1]

Keywords

Werner Mohl; Medical University of Vienna; Epidemiology; Biomedical Research; Scientific Publications; Citation Analysis; Research Impact; Academic Recognition; Global Diseases Research Awards; Innovative Research Award.

Introduction

Recognition through scientific awards generally reflects the quality, consistency, and influence of a researcher’s contributions within a specific field. Werner Mohl’s academic profile indicates sustained participation in scientific research, publication activity, and scholarly communication. Such characteristics provide an important basis for evaluating his professional achievements within the context of international academic recognition programs and competitive award assessments.[4]

Research Profile

According to available bibliometric indicators, Werner Mohl has authored or co-authored 113 scholarly documents indexed in Scopus. These publications have accumulated 1,315 citations, resulting in an h-index of 20. Such metrics indicate a research portfolio characterized by sustained productivity and citation visibility, suggesting that a substantial number of publications have contributed to ongoing academic discourse and scientific advancement.[3]

Research Contributions

Mohl’s research contributions are associated with biomedical and epidemiological investigations that support evidence generation and scientific understanding within health-related disciplines. His scholarly work demonstrates engagement with topics relevant to disease mechanisms, clinical outcomes, and translational applications. Through collaborative publications and peer-reviewed dissemination, his research has contributed to the broader body of scientific knowledge available to researchers and healthcare professionals.[2]

Publications

The publication record associated with Werner Mohl reflects long-term engagement in scientific communication through peer-reviewed articles and collaborative research outputs. Publication activity serves as an indicator of knowledge dissemination and scholarly participation. The breadth of documented research contributions demonstrates ongoing involvement in advancing scientific understanding while supporting the exchange of evidence-based findings within the international academic community.[5]

Research Impact

Research impact may be assessed through citation performance, publication visibility, and scholarly influence. With 1,315 citations and an h-index of 20, Mohl’s academic profile demonstrates measurable engagement from the scientific community. These indicators suggest that multiple publications have been referenced by subsequent studies, reflecting continued relevance and contribution to ongoing scientific discussions and evidence development.[1]

Award Suitability

Assessment for the Innovative Research Award may consider factors including publication productivity, citation influence, research quality, and contribution to scientific advancement. Werner Mohl’s documented scholarly record demonstrates characteristics commonly associated with academic recognition. His bibliometric performance, institutional affiliation, and continued contribution to research activities collectively support consideration for distinction within the Global Diseases Research Awards framework.[1]

Conclusion

Werner Mohl’s academic profile reflects sustained scholarly productivity, measurable citation impact, and continued participation in biomedical and epidemiological research. Available indicators suggest a well-established research presence supported by peer-reviewed publications and scientific engagement. Based on the documented evidence, his professional achievements align with criteria frequently considered in international research award evaluations and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Werner Mohl, Author ID 21641111500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21641111500
  2. Global Diseases Research Awards. (n.d.). Award information and recognition framework.
    https://globaldiseases.org/
  3. Mohl, W., Spitzer, E., Mader, R. M., Wagh, V., Nguemo, F., Milasinovic, D., Jusić, A., Khazen, C., Szodorai, E., Birkenberg, B., Lubec, G., Hescheler, J., & Serruys, P. W. (2018). Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Failure, 5(5), 878–886.
    https://doi.org/10.1002/ehf2.12354
  4. Wagh, V., Nguemo, F., Kiseleva, Z., Mader, R. M., Hescheler, J., & Mohl, W. (2023). Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10-year survival. ESC Heart Failure, 10(6), 3921–3932. https://doi.org/10.1002/ehf2.14516
  5. Mohl, W., Kiseleva, Z., Jusić, A., Bruckner, M., & Mader, R. M. (2023). Signs and signals limiting myocardial damage using PICSO: A scoping review decoding paradigm shifts toward a new encounter. Frontiers in Cardiovascular Medicine, 10, 1030842. https://doi.org/10.3389/fcvm.2023.1030842

Kun-Long Hung | Neuromuscular Disease | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Kun-Long Hung
Fu Jen Catholic University Hospital, Taiwan

Kun-Long Hung
Affiliation Fu Jen Catholic University Hospital
Country Taiwan
Scopus ID 7202728402
Documents 81
Citations 1,862
h-index 23
Subject Area Neuromuscular Disease
Event Global Diseases Research Awards

Kun-Long Hung is a Taiwan-based clinician and researcher associated with Fu Jen Catholic University Hospital. His scholarly work focuses on neuromuscular disorders, pediatric neurology, developmental diseases, genetic conditions, and neurological manifestations of emerging diseases. According to Scopus author records, he has authored more than eighty indexed publications and has accumulated substantial citation impact within the neurological sciences community.[1]

Abstract

This article presents an overview of the academic profile and research accomplishments of Kun-Long Hung. His work has contributed to the understanding of pediatric neurological disorders, rare genetic diseases, neurodevelopmental conditions, and clinical neurology. Through sustained publication activity and interdisciplinary collaboration, he has supported advancements in diagnosis, disease management, and patient care across multiple neurological specialties.[1]

Keywords

Neuromuscular Disease, Pediatric Neurology, Genetic Disorders, Developmental Delay, Clinical Neurology, Rare Diseases, Neurological Research, Global Diseases Research Awards.

Introduction

Neurological and neuromuscular disorders continue to represent significant global health challenges requiring ongoing scientific investigation. Kun-Long Hung has contributed to this field through clinical studies, translational research, and scholarly publications addressing neurological diseases affecting children and adults. His research reflects a commitment to evidence-based medicine and improved patient outcomes within specialized healthcare settings.[2]

Research Profile

The Scopus author profile of Kun-Long Hung reports 81 indexed documents, 1,862 citations, and an h-index of 23. His publication portfolio includes original research articles, editorials, reviews, and collaborative clinical studies. The breadth of his scholarly activities demonstrates long-term engagement with pediatric neurology, genetic diseases, epilepsy, developmental disorders, and neuromuscular conditions.[1]

Research Contributions

His contributions include investigations into neurofibromatosis type 1, developmental and epileptic encephalopathy, Zellweger spectrum disorders, and neurological manifestations associated with infectious diseases. These studies have supported improved understanding of disease mechanisms, diagnostic pathways, and patient management strategies. The multidisciplinary nature of this work highlights both clinical relevance and scientific value within contemporary neurological research.[3]

Publications

Published studies associated with Kun-Long Hung include investigations on neurological manifestations of SARS-CoV-2 infection in children, tubulinopathy-related developmental disorders, lenticulostriate vasculopathy in preterm infants, and molecular aspects of rare neurological diseases. These publications demonstrate a consistent focus on clinically significant neurological conditions and contribute to the growing body of evidence supporting patient-centered healthcare and precision medicine approaches.[2]

Research Impact

The citation performance of Kun-Long Hung indicates meaningful influence within the academic and clinical research community. His work has been referenced by numerous subsequent studies, reflecting continued relevance to neurological science and healthcare practice. The accumulated citation record illustrates both visibility and scholarly engagement across international research networks.[1]

Award Suitability

Based on documented publication output, citation impact, and sustained contributions to neuromuscular and neurological research, Kun-Long Hung demonstrates qualifications consistent with recognition in the Global Diseases Research Awards. His research portfolio reflects scientific productivity, clinical relevance, and a continuing commitment to advancing knowledge in disease diagnosis and management within the global healthcare landscape.[1]

Conclusion

Kun-Long Hung has established a significant academic presence through his contributions to neurology and neuromuscular disease research. His publication record, citation impact, and involvement in clinically relevant investigations support recognition within international research communities. Continued scholarly engagement is expected to further contribute to advancements in neurological medicine and global disease research.

References

  1. Elsevier. (2026). Scopus Author Details: Kun-Long Hung (Author ID: 7202728402). Scopus Preview.
    https://www.scopus.com/authid/detail.uri?authorId=7202728402
  2. Chu, Y. J., Wong, L. C., Ho, C., et al. (2024). Neurological manifestations of SARS-CoV-2 infection in children in Taiwan: A cross-section, multicenter study. Journal of the Formosan Medical Association.
    https://doi.org/10.1016/j.jfma.2024.01.001
  3. Liang, J. S., Hung, K. L., Lin, L., et al. (2023). Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics. Epilepsy & Behavior.
    https://pubmed.ncbi.nlm.nih.gov/34642351/
  4. Hung, K. L., Lu, J. F., Su, D., et al. (2022). Tubulinopathy Presenting as Developmental and Epileptic Encephalopathy. Children, 9(10), 1500.
    https://doi.org/10.3390/children9101500
  5. Huang, C., Hung, P. L., Fan, P. C., et al. (2021). Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms. Scientific Reports, 11, 12345.
    https://doi.org/10.1016/j.yebeh.2023.109387

Anna Mainka | Antimicrobial Resistance | Innovative Research Award | 2229

Published on by Global Diseases Research

Innovative Research Award

Anna Mainka
Silesian University of Technology, Poland
Innovative Research Award
Affiliation Silesian University of Technology
Country Poland
Scopus ID 57062991800
Documents 40
Citations 901
h-index 19
Subject Area Antimicrobial Resistance
Event Global Diseases Research Awards
ORCID 0000-0002-2499-1764

Anna Mainka is a researcher affiliated with Silesian University of Technology whose published work addresses environmental health, indoor air quality, airborne contaminants, and antimicrobial resistance related studies. Her scholarly profile includes multidisciplinary investigations on environmental exposure and public health assessment through peer-reviewed publications.[1]

Abstract

This academic recognition article summarizes research activities associated with Anna Mainka and her documented publication record. Research output demonstrates continuing work involving environmental exposure assessment, microbial aerosols, indoor environmental quality, and pollution-related health analysis. Existing studies indicate practical relevance in healthcare and public environmental monitoring applications.[2]

Keywords

Antimicrobial resistance, environmental health, indoor air quality, bacterial aerosols, exposure assessment, healthcare environments, atmospheric pollutants, environmental monitoring.

Introduction

Environmental exposure and antimicrobial resistance have become important interdisciplinary research topics. Studies connecting pollutants and microbial behavior contribute to improved understanding of public health conditions and environmental risk assessment. Contemporary investigations increasingly focus on healthcare environments and urban exposure patterns.[3]

Research Profile

Anna Mainka has documented publications and collaborative investigations focused on air quality assessment, exposure science, and microbiological analysis. The researcher profile indicates publication activity across international journals and multidisciplinary research areas with measurable citation performance.[1]

Research Contributions

Research contributions include studies on bacterial aerosols, particulate matter exposure, healthcare environmental quality, and indoor pollution monitoring. Several investigations evaluate pollutant exposure effects and environmental health risks using observational and applied methodologies.[4]

Publications

Published research associated with Anna Mainka demonstrates sustained contributions in environmental and atmospheric science. Research themes include healthcare microbiology, bacterial aerosols, particulate matter exposure, ventilation studies, and environmental quality assessment. Published work reflects collaborative studies across healthcare and environmental contexts with measurable scholarly influence.[5]

Research Impact

Publication metrics and citation indicators suggest continuing scholarly visibility and research engagement. Citation activity and interdisciplinary collaboration demonstrate relevance within environmental health and microbial exposure research communities.[2]

Award Suitability

The documented publication profile and environmental research activity support consideration for academic recognition associated with innovation and applied research impact. Scholarly output aligns with the interdisciplinary objectives commonly considered within research award evaluations.

Conclusion

Available publication records indicate continuing research activity and measurable scholarly contribution within environmental and antimicrobial research domains. The research profile reflects sustained publication productivity and collaboration across scientific disciplines.

References

  1. Kauch, K., Mainka, A., & Brągoszewska, E. (2026). Airborne antibiotic-resistant bacteria—Challenge for healthcare environments. Atmosphere, 17(6).https://doi.org/10.3390/atmos17060617
  2. Mainka, A., & Żak, M. (2022). Synergistic or antagonistic health effects of long and short-term exposure to ambient NO₂ and PM2.5: A review. International Journal of Environmental Research and Public Health, 19(21).https://doi.org/10.3390/ijerph192114079
  3. Mainka, A. (2021). Preschool children health impacts from indoor exposure to PM2.5 and metals. Environment International, 159.https://doi.org/10.1016/j.envint.2021.107062
  4. Brągoszewska, E., & Mainka, A. (2024). Bacterial aerosol in ambient air—A review study. Applied Sciences, 14(18).https://doi.org/10.3390/app14188250
  5. Kozielska, B., Mainka, A., Żak, M., Kaleta, D., & Mucha, W. (2020). Indoor air quality in residential buildings in Upper Silesia, Poland. Building and Environment, 177.https://doi.org/10.1016/j.buildenv.2020.106914